Cynbiose (FR) and Motac Neurosciences (UK, CN) sign a strategic partnership in metabolic disorders.

Lyon, January 8th, 2019 – Cynbiose SAS and Motac Neurosciences Ltd, two CRO specialised in preclinical services for the biopharmaceutical industry sign a strategic partnership to commercialize an integrated offer for exploratory and pharmacokinetics studies.

Both companies also agreed to co-develop innovative and proprietary preclinical models in metabolic disorders.

Contact us for more information.